Lucem Health

Lucem Health provides a platform designed to integrate clinical artificial intelligence (AI) into the daily workflows of healthcare providers. The company was founded in 2021 through a partnership between the Mayo Clinic and CEO Sean Cassidy. The idea originated within the Mayo Clinic, which was seeking a more effective way to deploy its AI and machine learning innovations from a research setting to practical, bedside applications. Sean Cassidy, who has over two decades of experience in digital health, particularly in data integration, management, and analytics platforms for large provider organizations, was brought on to lead this new venture. Prior to Lucem Health, Cassidy was the CEO of Corepoint Health, leading it through a merger with Rhapsody.

The company's core business revolves around an AI-agnostic platform that helps healthcare organizations operationalize AI-powered solutions. It acts as a bridge between AI model developers and clinicians, taking data from various sources like electronic health records (EHRs), normalizing it, and connecting it to any AI algorithm. The resulting insights are then delivered into existing clinical systems, aiming to avoid disruption to established processes. This model allows hospitals and clinics to build, train, and scale AI models using their own data. Lucem Health's primary revenue stream comes from subscription fees for its cloud-based platform and solutions.

The company's target market consists of healthcare organizations, such as hospitals and clinics, looking to leverage AI for earlier disease detection and to optimize care. Notable clients include the Mayo Clinic Platform and Mercy Hospital St. Louis. One of the company's key product lines is Lucem Health Reveal, a suite of solutions that uses AI to analyze existing clinical data and identify patients at higher risk for serious or chronic conditions like diabetes, colorectal cancer, and stroke. The objective is to enable earlier intervention, which can improve patient outcomes and provide financial benefits to healthcare organizations. A significant milestone for the company was securing $7.7 million in a Series A funding round in May 2023, led by Mayo Clinic, Granger Management, and Mercy, with participation from existing investor Rally Ventures. This capital is intended to advance the platform's development, expand the solution portfolio, and scale sales and marketing efforts.

Keywords: clinical AI deployment, healthcare analytics, early disease detection, point-of-care solutions, digital health platform, machine learning in healthcare, clinical workflow integration, patient risk identification, Mayo Clinic, health IT, predictive analytics, healthcare data integration, Reveal platform, Sean Cassidy, chronic disease management, healthcare AI solutions, medical diagnostics, AI-agnostic platform, care delivery optimization, health tech